# Endo Statin Therapy T1d Obesity High Tg Low Hdl

> Suggests statin therapy, irrespective of the cardiovascular risk score, to reduce cardiovascular risk in adults with type 1 diabetes who have obesity or who have high triglycerides and low HDL-C. Clinical triggers include "T1D patient with obesity", "T1D with high TG and low HDL-C", and "Assessing statin need in T1D with metabolic syndrome features".

- Skill: `dromlakhani/endo-statin-therapy-t1d-obesity-high-tg-low-hdl` (Agent Skill)
- Install (CLI): `npx skillmds@latest add dromlakhani/endo-statin-therapy-t1d-obesity-high-tg-low-hdl`
- Raw SKILL.md: https://api.skillmd.com/api/skills/dromlakhani/endo-statin-therapy-t1d-obesity-high-tg-low-hdl/raw
- Safety review: pending (external: skill-scanner PASS, skillspector PASS)
- Works with: Claude Code, Claude.ai, OpenAI Codex
- Category: Coding & Dev Tools
- Author: dromlakhani (https://skillmd.com/u/dromlakhani)
- Updated: 2026-09-08
- Page: https://skillmd.com/skills/dromlakhani/endo-statin-therapy-t1d-obesity-high-tg-low-hdl

---


# Statin therapy for type 1 diabetes with obesity or high triglycerides and low HDL-C

## STEP 1 — Gather Information
Collect age, duration of type 1 diabetes, BMI or waist circumference (obesity: BMI ≥30 kg/m2 or waist ≥102 cm men/≥88 cm women, adjusting for ethnicity), fasting lipid panel (TG, HDL-C, LDL-C), assess pregnancy status or plans, review current medications for interactions, and note microvascular complications.

## STEP 2 — Rule In / Rule Out
If the patient has type 1 diabetes AND (obesity OR (fasting TG ≥150 mg/dL AND HDL-C <50 mg/dL in women or <40 mg/dL in men)), rule in for statin consideration; otherwise, rule out statin initiation based solely on this criterion.

## STEP 3 — Classify or Stratify
If rule in, classify LDL-C level: LDL-C >70 mg/dL (1.8 mmol/L) as high LDL-C; LDL-C ≤70 mg/dL as not elevated.

## STEP 4 — Decide
If LDL-C >70 mg/dL, initiate moderate- or high-intensity statin after discussing risks/benefits; if LDL-C ≤70 mg/dL, discuss potential statin use weighing patient preferences, presence of obesity/metabolic syndrome features, and shared decision-making.

## Clinical Guardrails / Mimics / Pitfalls
Do not prescribe statins to pregnant individuals or those trying to become pregnant; monitor for myopathy, hepatic transaminases, and drug interactions (e.g., with macrolides, azole antifungals); avoid relying on statin therapy without concurrent lifestyle modification; consider statin intolerance if CK >10× ULN or unexplained muscle symptoms; do not use fibrates as first-line for LDL-C reduction in this population unless TG >500 mg/dL.

## Concrete Clinical Example
A 46-year-old woman with T1D for 12 years presents with BMI 34, TG 190 mg/dL, HDL-C 36 mg/dL, LDL-C 115 mg/dL. She meets criteria for obesity and high TG/low HDL-C. LDL-C >70 mg/dL, so after discussing benefits and muscle symptom risk, atorvastatin 20 mg daily is started.

**Source:** Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2020, doi:10.1210/clinem/dgaa674
> **TODO:** consider adding scripts/calc.py for the endo-statin-therapy-t1d-obesity-high-tg-low-hdl calculator